Blog
RSS FeedPosted by Michael Wonder on 17 Oct 2019
Canadian breakthrough that became the world's most expensive drug, then vanished, gets second chance
17 October 2019 - CBC story about how pharmaceutical industry abandoned gene therapy Glybera sparks NRC effort to re-invent it. ...
Posted by Michael Wonder on 16 Oct 2019
Election 2019: unprecedented hope for universal pharmacare
15 October 2019 - Pharmacare continues to be the most salient unfinished business of Canada’s public health care system since Medicare ...
Posted by Michael Wonder on 09 Oct 2019
Low-income Canadians struggling to pay for medications plead for pharmacare
8 October 2019 - Three of the major federal parties have promised they’ll introduce universal pharmacare if elected. ...
Posted by Michael Wonder on 24 Sep 2019
9 in 10 Canadians want national pharmacare: Heart & Stroke poll
24 September 2019 - Canadians overwhelmingly support a national pharmacare program, according to a new poll commissioned by Heart & ...
Posted by Michael Wonder on 24 Sep 2019
Trudeau pledges $6 billion to kickstart talks on health care, national pharmacare with provinces
23 September 2019 - A re-elected Liberal government would introduce a national pharmacare program, Justin Trudeau promised Monday — though ...
Posted by Michael Wonder on 24 Sep 2019
Canadian Health Policy Institute reports national pharmacare is unnecessary, bad for privately insured Canadians and costly for taxpayers: evidence counters Hoskins report
24 September 2019 - Constructive public discussion about a national pharmacare program in Canada is hindered by a lack of balance ...
Posted by Michael Wonder on 16 Sep 2019
Canada decides: Leading parties plan to tackle ways to make medicine affordable
16 September 2019 - Canadian voters will be hearing a lot about a new national prescription drug program to fill a ...
Posted by Michael Wonder on 12 Sep 2019
Public plans covered only 26% of the 491 new drugs approved by Health Canada from 2009 to 2018; national pharmacare is an empty promise for 23.2 million Canadians now covered by private plans
11 September 2019 - Two new studies confirm the abysmal state of access to innovative medicines in Canada’s publicly funded drug ...
Posted by Michael Wonder on 12 Sep 2019
New rules will keep the best medications from desperate Canadians
12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...
Posted by Michael Wonder on 01 Sep 2019
'Outrageously expensive': new drug approval will cost Ontario family 100K per year
30 August 2019 - Drug cost jumped from $5,000 to more than $100,000 per year. ...
Posted by Michael Wonder on 06 Aug 2019
Knight Therapeutics and pan-Canadian Pharmaceutical Alliance reach agreement for Probuphine for opioid dependence
6 August 2019 - AB, SK and NIHB are the first public drug plans to fund Probuphine recognising benefits of new ...
Posted by Michael Wonder on 31 Jul 2019
Could Quebec’s public drug plan work for national pharmacare?
30 July 2019 - Quebec’s universal pharmacare program offers better drug coverage and quicker approval for new drugs coming to ...
Posted by Michael Wonder on 25 Jul 2019
Quebec’s public-private pharmacare model provides more generous—and timely—access to new drugs
25 July 2019 - Quebec’s universal pharmacare system, which relies on both a public plan and private insurance providers, covers ...
Posted by Michael Wonder on 20 Jul 2019
Biosimilar drugs a boon to be applauded as they provide equivalent treatment at – sometimes – half the price
19 July 2019 - The fastest-growing segment of our health-care system is prescription drugs – now constituting the second-highest category ...
Posted by Michael Wonder on 07 Jul 2019
Life-changing drug Spinraza still not covered for many Canadians with spinal muscular atrophy
4 July 2019 - For several hundred Canadians with spinal muscular atrophy, Spinraza is a drug that means the difference ...